Gastroenterology

CME Exam 3: Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-analysis



CME Exam 3: Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-analysis

Source link

Related posts

What are the best natural H. pylori treatments?

Newsemia

Study: Micronutrient deficiencies are common in adults at the time of celiac disease diagnosis

Newsemia

Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy